Investing Profile

Stacie Weninger

InvestorVC
President, FBRI at F-Prime Capital Partners
Photo of Stacie Weninger, President at F-Prime Capital Partners

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
$100K - $10.0M
$5.0M
5
CompanyStageDateRound SizeTotal Raised
Engrail Therapeutics
Series BMar 2024$160M
$220M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Jasper Bos (Forbion), Niall O’Donnell (RiverVest), Heath Lukatch (Red Tree Venture Capital)
Neumora Therapeutics
Series AOct 2021$400M
$510M
Co-investors: Kristina Burow (ARCH Venture Partners), Robert Nelsen (ARCH Venture Partners), Alaa Halawa
Atalanta Therapeutics
Series AJan 2021$110M
$110M
Co-investors: Stephen Knight (F-Prime Capital Partners), Jessica Alston (F-Prime Capital Partners)
Denali Therapeutics
Series BAug 2016$130M
Series AMay 2015$220M
$350M
Co-investors: Doug Cole (Flagship Ventures), Robert Nelsen (ARCH Venture Partners)